This is a preview of subscription content, log in via an institution to check access.
Notes
angiotensin converting enzyme inhibitor (ACEI), beta-blocker (BB), aldosterone antagonist (AldA)
New York Heart Association
2012 values
Reference
Banka G, et al. Incremental Cost-Effectiveness of Guideline-Directed Medical Therapies for Heart Failure. Journal of the American College of Cardiology : 14 Feb 2013. Available from: URL: http://dx.doi.org/10.1016/j.jacc.2012.12.022
Rights and permissions
About this article
Cite this article
Guideline-directed treatment highly cost effective in heart failure. PharmacoEcon Outcomes News 673, 8 (2013). https://doi.org/10.1007/s40274-013-0214-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0214-z